RhumbLine Advisers’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $431K | Buy |
65,093
+11,133
| +21% | +$73.7K | ﹤0.01% | 2780 |
|
|
2025
Q1 | $494K | Sell |
53,960
-873
| -2% | -$7.99K | ﹤0.01% | 2584 |
|
|
2024
Q4 | $576K | Buy |
54,833
+297
| +0.5% | +$3.12K | ﹤0.01% | 2585 |
|
|
2024
Q3 | $652K | Buy |
54,536
+2,099
| +4% | +$25.1K | ﹤0.01% | 2529 |
|
|
2024
Q2 | $302K | Buy |
52,437
+51,478
| +5,368% | +$296K | ﹤0.01% | 3001 |
|
|
2024
Q1 | $4.99K | Hold |
959
| – | – | ﹤0.01% | 3985 |
|
|
2023
Q4 | $5.05K | Hold |
959
| – | – | ﹤0.01% | 3983 |
|
|
2023
Q3 | $3.16K | Sell |
959
-3,817
| -80% | -$12.6K | ﹤0.01% | 4051 |
|
|
2023
Q2 | $13.8K | Sell |
4,776
-43,000
| -90% | -$124K | ﹤0.01% | 3871 |
|
|
2023
Q1 | $51K | Buy |
47,776
+277
| +0.6% | +$296 | ﹤0.01% | 2905 |
|
|
2022
Q4 | $124K | Buy |
47,499
+156
| +0.3% | +$407 | ﹤0.01% | 2878 |
|
|
2022
Q3 | $331K | Buy |
47,343
+2,626
| +6% | +$18.4K | ﹤0.01% | 2687 |
|
|
2022
Q2 | $305K | Buy |
44,717
+16,517
| +59% | +$113K | ﹤0.01% | 2743 |
|
|
2022
Q1 | $398K | Buy |
28,200
+8,055
| +40% | +$114K | ﹤0.01% | 2523 |
|
|
2021
Q4 | $292K | Buy |
+20,145
| New | +$292K | ﹤0.01% | 2713 |
|